A report released at the 2026 Brain-Computer Interface Conference in Beijing said China’s industry is concentrated in the Beijing-Tianjin-Hebei region, the Yangtze River Delta and the Guangdong-Hong Kong-Macao Greater Bay Area, with an emerging innovation-to-manufacturing ecosystem. Global brain-computer interface companies numbered 1,175 in 2026, rising rapidly from 2025, as the industry faces a reshuffling. China and the United States are competing for influence across technology, applications

2026-11-21

A report released at the 2026 Brain-Computer Interface Conference in Beijing said China’s industry is concentrated in the Beijing-Tianjin-Hebei region, the Yangtze River Delta and the Guangdong-Hong Kong-Macao Greater Bay Area, with an emerging innovation-to-manufacturing ecosystem. Global brain-computer interface companies numbered 1,175 in 2026, rising rapidly from 2025, as the industry faces a reshuffling. China and the United States are competing for influence across technology, applications, ecosystems and governance. Industry revenue is concentrated in research and healthcare, while many medical devices remain in development, clinical trials or regulatory review. Non-medical applications are at an early stage, with scope for growth in human-computer interaction and consumer electronics.